About this app

* This app is intended only for those who participate in the "Randomized controlled trial examining the usefulness of ePRO monitoring during the T-DXd treatment period in unresectable or recurrent breast cancer".

In order to use this app, it is necessary to meet the participation criteria for research and to register for participation through the research participation facility.